Provided by Tiger Fintech (Singapore) Pte. Ltd.

Surgery Partners

22.24
-0.1300-0.58%
Volume:110.03K
Turnover:2.44M
Market Cap:2.83B
PE:-14.52
High:22.35
Open:22.12
Low:22.07
Close:22.37
Loading ...

Surgery Partners Misses Q1 Marks But Sticks To 2025 Outlook

Benzinga
·
12 May

BUZZ-Surgery Partners rise after Q1 results

Reuters
·
12 May

Surgery Partners Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
12 May

Stock Track | Surgery Partners Drops 5.23% Pre-Market on Q1 Earnings Miss and Revenue Shortfall

Stock Track
·
12 May

Surgery Partners Q1 Adjusted Earnings Fall, Revenue Rises; 2025 Sales Outlook Reaffirmed

MT Newswires Live
·
12 May

GUIDANCE: (SGRY) Surgery Partners Expects 2025 Revenue Range $3.3B - $3.45B, vs. FactSet Est of $3.39B

MT Newswires Live
·
12 May

Earnings Flash (SGRY) Surgery Partners Posts Q1 Revenue $776M, vs. FactSet Est of $777.3M

MT Newswires Live
·
12 May

Surgery Partners Q1 2025 Adj. EPS $0.04 Misses $0.05 Estimate, Sales $776.00M Miss $777.07M Estimate

Benzinga
·
12 May

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
12 May

3 Healthcare Stocks with Mounting Challenges

StockStory
·
24 Apr

RXO, The Ensign Group, LifeStance Health Group, Surgery Partners, and Guardant Health Stocks Trade Down, What You Need To Know

StockStory
·
22 Apr

Surgery Partners Price Target Maintained With a $35.00/Share by Benchmark

Dow Jones
·
21 Apr

Analysts Offer Insights on Healthcare Companies: Regeneron (REGN) and Surgery Partners (SGRY)

TIPRANKS
·
21 Apr

Surgery Partners, Inc. Announces First Quarter 2025 Earnings Release Date and Conference Call Details

GlobeNewswire
·
19 Apr

Outpatient & Specialty Care Stocks Q4 Teardown: Encompass Health (NYSE:EHC) Vs The Rest

StockStory
·
18 Apr

3 Reasons SGRY is Risky and 1 Stock to Buy Instead

StockStory
·
07 Apr

Surgery Partners Price Target Maintained With a $35.00/Share by RBC Capital

Dow Jones
·
25 Mar

RBC Capital Sticks to Its Buy Rating for Surgery Partners (SGRY)

TIPRANKS
·
25 Mar

Surgery Partners Is Maintained at Outperform by Macquarie

Dow Jones
·
11 Mar

Macquarie Trims Price Target on Surgery Partners to $33 From $34, Keeps Outperform Rating

MT Newswires Live
·
11 Mar